Trial Profile
Phase II trial of buffy coat interleukins in patients with head and neck cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Mar 2010
Price :
$35
*
At a glance
- Drugs Buffy coat interleukins (Primary)
- Indications Head and neck cancer
- Focus Proof of concept; Therapeutic Use
- Sponsors CEL-SCI Corporation